Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Mesa Laboratories's revenue per share for the
three
months ended in Jun. 2026 was $10.45.
Mesa Laboratories's revenue per share for the trailing twelve months (TTM) ended in Jun. 2026 was $44.49.
Warning Sign:
Mesa Laboratories Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of Mesa Laboratories was 0.50% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 3.10% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 10.30% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 7.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Mesa Laboratories's Revenue per Share or its related term are showing as below:
MLAB'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0.8 Med: 11.3 Max: 26.3
Current: 3.1
During the past 13 years, Mesa Laboratories's highest 3-Year average Revenue Per Share Growth Rate was 26.30% per year. The lowest was 0.80% per year. And the median was 11.30% per year.
MLAB's 3-Year Revenue Growth Rate is ranked better than 56.11% of 2406
companies
in the Hardware industry
Industry Median: 1.35
vs MLAB: 3.10
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Mesa Laboratories Revenue per Share Related Terms
Mesa Laboratories Revenue per Share Historical Data
* Premium members only.
The historical data trend for Mesa Laboratories's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MLAB vs AERG, USBC, WRAP: Revenue per Share Comparison
For the Scientific & Technical Instruments subindustry, Mesa Laboratories's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mesa Laboratories PS Ratio vs Hardware Industry
For the Hardware industry and Technology sector, Mesa Laboratories's PS Ratio distribution charts can be found below:
* The bar in red indicates where Mesa Laboratories's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Mesa Laboratories's Revenue Per Share for the fiscal year that ended in Mar. 2026 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $44.49
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mesa Laboratories (MLAB) has a Revenue per Share of $44.49 as of Jun. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Mesa Laboratories and its competitors. According to the industry distribution chart, Mesa Laboratories ranks #1056 out of 2406 companies in the Hardware industry, placing it in the top 43.9%.
Is Mesa Laboratories' Revenue per Share too high?
Mesa Laboratories' current Revenue per Share is $44.49. The Hardware industry median Revenue per Share is 1.35. Mesa Laboratories' value of $44.49 is 3195.6% above this industry median. Based on the distribution chart, Mesa Laboratories ranks #1056 out of 2406 companies in the Hardware industry, which is above the industry midpoint. Overall, Mesa Laboratories has a GF Score™ of 75/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Mesa Laboratories' Revenue per Share compare to AERG and USBC?
According to the Hardware industry distribution chart, Mesa Laboratories ranks #1056 out of 2406 companies for Revenue per Share. This puts Mesa Laboratories in the upper half of its industry. The industry median Revenue per Share is 1.35. Mesa Laboratories' value of $44.49 is 3195.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Hardware company?
The median Revenue per Share among Hardware companies is 1.35, based on 2,406 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mesa Laboratories's current Revenue per Share of $44.49 is 3195.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Mesa Laboratories and its competitors. For the Hardware industry, the median Revenue per Share is 1.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mesa Laboratories's current Revenue per Share is $44.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mesa Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mesa Laboratories (MLAB) is currently considered Modestly Overvalued. The stock's GF Value™ is $106.26, compared to a current price of $124.38 — trading 17.1% above its estimated fair value. The current Revenue per Share is $44.49 and 3195.6% above the Hardware industry median of 1.35. Mesa Laboratories' overall GF Score™ is 75/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Mesa Laboratories (MLAB), the current Revenue per Share is $44.49 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mesa Laboratories (MLAB) Overvalued in 2026?
Based on GuruFocus' analysis, Mesa Laboratories stock appears to be overvalued.
The current stock price of $124.38 is trading 17.1% above its estimated GF Value™ of $106.26.
GuruFocus considers Mesa Laboratories to be Modestly Overvalued.
Key valuation signals for MLAB:
Revenue per Share: $44.49
GF Value™: $106.26 vs. price of $124.38 (17.1% above fair value)
Industry Position: 3195.6% above the Hardware median (#1056 of 2406)
No single metric tells the full story. See the MLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
75GF Score
Get the complete analysis for MLAB
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MLAB has been successfully added to your 
